Dr. Sarat Chandarlapaty

Dr. Sarat Chandarlapaty, MD, PhD, is a medical oncologist with a practice devoted exclusively to treating patients with breast cancer at Memorial Sloan Kettering Cancer Center. Driven by a long-standing commitment to translating scientific discoveries into meaningful treatments, he chose oncology to help people affected by one of the most significant health challenges of our time. His dual focus on laboratory and clinical research reflects a deep dedication to understanding and overcoming the biological obstacles that limit current therapies.

Dr. Chandarlapaty's research centers on developing new treatment strategies for breast cancers that have become resistant to standard therapies. His laboratory investigates the molecular factors that drive resistance, with the goal of identifying new therapeutic targets. Working alongside an exceptional team of physicians and scientists, he explores novel inhibitors that block pathways enabling breast cancer growth or drug resistance, as well as treatments designed to deliver therapy directly and specifically to cancer cells. His work also includes the investigation of antibody drug conjugates, hybrid agents that combine the mechanisms of immunotherapy and chemotherapy to enable more targeted and precise treatment approaches.

Through his integrated approach to clinical care and translational research, Dr. Chandarlapaty remains focused on the shared goal of eradicating breast cancer. His work on targeted biological therapies and resistance mechanisms continues to open new avenues for patients whose cancers have stopped responding to conventional treatment. His commitment to scientific collaboration and patient-centered care reflects both the rigor and the compassion that define his practice.